Latest filing published 12 Nov 2014 for Codexis, INC., €5.2M.
Insider track record
No signal scores available.
Cmea Ventures Life Sciences 2000 LP: trading record in brief
Cmea Ventures Life Sciences 2000 LP is a declared insider of Codexis, Inc., with filings sourced from SEC (Form 4). We count 8 filings; the first trade dates from 27 April 2010 and the latest from 10 November 2014.
No open-market purchase appears, only 2 sales worth €5.6M. Since January 2014: no purchases and 2 sales on the market.
On 12 November 2014 came the latest disclosure, an open-market sale for €5.2M in Codexis, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Cmea Ventures Life Sciences 2000 LP
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,740,158 shares@ US$2.37Common StockSEC:0001209191-14-068117:0
- 181,067 shares@ US$2.37Common StockSEC:0001209191-14-068117:1
- 371,043 sharesCommon StockSEC:0001181431-10-023529:5
- 950,638 sharesCommon StockSEC:0001181431-10-023529:4
- 93,727 sharesCommon StockSEC:0001181431-10-023529:0
- 62,815 sharesCommon StockSEC:0001181431-10-023529:1
- 24,525 sharesCommon StockSEC:0001181431-10-023529:2
- 1,418,477 sharesCommon StockSEC:0001181431-10-023529:3
8 of 8 declarations
